Grzegorz Sienski

I am a Head of Bioscience Technology in Early CVRM Bioscience at AstraZeneca. My current focus spans laboratory automation, high-throughput molecular assays, advanced imaging, omics, data science, and human-relevant cellular models, with increasing emphasis on AI-ready experimental workflows and data generation. I trained as a molecular biologist and geneticist at the Institute of Molecular Biotechnology (IMBA) in Vienna. I subsequently joined the Whitehead Institute and MIT working on protein homeostasis, disease mechanisms and functional genomics. At AstraZeneca, I previously led the Genome Editing Technology team in Discovery Sciences, where my work focused on developing and applying CRISPR-based technologies for target discovery and therapeutic research, including next-generation nucleases, and other precision genome-engineering approaches. In my current role, I work at the interface of biology and technology to generate higher-quality, more scalable and more mechanistically inform